Ignite Creation Date:
2024-06-16 @ 11:49 AM
Last Modification Date:
2024-10-26 @ 3:31 PM
Study NCT ID:
NCT06439199
Status:
RECRUITING
Last Update Posted:
2024-06-03
First Post:
2024-02-09
Brief Title:
Biological Prospective Study Evaluating the Dosage of Plasma Cytokines Including the FLT3 Ligand and IL6 of Patients Treated With Non-intensive Chemotherapy
Sponsor:
Organization:
Nantes University Hospital
Study Design
Study Type:
OBSERVATIONAL
Expanded Access Type Individual:
None
Expanded Access Type Intermediate:
None
Expanded Access Type Treatment:
None
Patient Registry:
False
Target Duration:
None
Design Allocation:
Design Intervention Model:
Design Intervention Model Description:
Design Masking Description:
Bio Spec Retention:
SAMPLES_WITHOUT_DNA
Bio Spec Description:
During the weekly blood samples taken in the day hospital as part of the treatment an additional 9 ml EDTA tube will be taken during the first 2 cycles for group 1 and during the first 3 cycles for group 2This additional tube will be used to supply this biocollection and to promote the development of knowledge in the field of acute myeloidblastic leukemia myelodysplasia and chronic myelomonocytic leukemia
Enrollment Count:
60
Enrollment Type:
ESTIMATED
Design Primary Purpose:
Design Masking:
Phases:
Observational Models:
| Name |
|---|
| Case-Only |
Time Perspective List:
Clinical Trial Statuses
| Name |
|---|
| 107336 |
Who Masked List: